marijuana stocks news

Cara Therapeutics Inc. (CARA)

 

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 914   1,125   960   178  
Cost of Revenue
Gross Profit 914   1,125   960   178  
Operating Expenses
Research Development 3,459 6,208 3,200 2,201
Selling General and Administrative 1,791 1,520 1,472 1,398
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (4,336) (6,603) (3,712) (3,421)
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes (4,314) (6,577) (3,656) (3,399)
Interest Expense
Income Before Tax (4,314) (6,577) (3,656) (3,399)
Income Tax Expense (142) (32) (11) (16)
Minority Interest
Net Income From Continuing Ops (4,172) (6,545) (3,645) (3,383)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (4,172) (6,545) (3,645) (3,383)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (4,172) (6,545) (3,645) (3,383)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Future Farm Technologies Inc. (FFRMF) Signs LOI to Acquire Controlling Interest in Massachusetts Dispensary and Grow Operation

Future Farm Signs LOI to Acquire Controlling Interest in Massachusetts Dispensary and…

Trulieve Cannabis Corp. (TCNNF) Announces Exclusive Partnership with DeLisioso Cannabis in Florida

Trulieve Announces Exclusive Partnership with DeLisioso Cannabis in Florida Trulieve Cannabis Corp.…

 InMed Pharmaceuticals Inc. (IMLFF) to Present at the H.C. Wainwright 20th Annual Global Investment Conference

InMed Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment…

$NDEV IR to Develop Comprehensive Investor Relations Program

Novus Engages Hayden IR to Develop Comprehensive Investor Relations Program Proactive Outreach…